VRSK Form 144: Proposed Sale of 1,100 Shares (~$294,811)
Verisk Analytics (VRSK) Form 144 reports a proposed sale of 1,100 shares of common stock to be executed through Merrill Lynch on 08/18/2025 on NASDAQ with an aggregate market value of $294,811.00.
Rhea-AI Filing Summary
Verisk Analytics (VRSK) Form 144 reports a proposed sale of 1,100 shares of common stock to be executed through Merrill Lynch on 08/18/2025 on NASDAQ with an aggregate market value of $294,811.00. The shares were acquired on 11/14/2021 upon vesting of restricted stock units granted under Verisk s equity compensation plan. The filer discloses a recent sale of 1,100 shares on 08/15/2025 generating $294,800.00 and identifies the seller as Lee Shavel. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.
Positive
- Transparent compliance with Rule 144 procedures including broker details and attestation
- Clear provenance showing shares were acquired via RSU vesting under issuer equity compensation plan
Negative
- Recent sale of identical size three days earlier may indicate continued insider selling, though size appears modest
Insights
TL;DR: Routine Rule 144 notice for vested equity; small-lot sale reported and planned; appears procedural and compliance-focused.
The filing documents a planned Rule 144 sale of 1,100 shares acquired via RSU vesting in 2021 and executed through Merrill Lynch on NASDAQ. The filing also records a near-term prior sale of the same quantity, suggesting tranche-based disposition of vested awards. This is a standard disclosure under Rule 144 and includes the required attestation regarding material nonpublic information. No indications of litigation, control transfers, or atypical financing arrangements are present in the text.
TL;DR: Transaction aligns with typical post-vesting sales of RSUs; size is small relative to a public company s float.
The securities were granted as part of the issuer s equity compensation plan and vested on 11/14/2021. The reported amounts (1,100 shares per transaction) and proceeds near $295k per tranche indicate routine disposition of employee-held equity rather than strategic insider divestiture. The filing contains necessary broker and sale scheduling details but provides no new information on ongoing compensation policy or broader insider liquidity patterns.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filed for VRSK report?
Through which broker will the proposed VRSK sale be executed?
Does the Form 144 state that the seller has undisclosed material information?
AI-generated analysis. How Rhea-AI works. Not financial advice.